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Abstract
Because intubation becomes a long procedure as potential, arterial oxygen (O
2
) desatu-
ration should be taken into account during the intubation. Since oxygen reserves are 
not always sufficient to meet the duration of intubation, preoxygenation should be 
routine before anesthetic induction and tracheal intubation. Surveys show that maxi-
mal preoxygenation increases oxygen reserves in the body and significantly delays 
arterial hemoglobin desaturation and hypoxia. In cases of respiratory insufficiency 
oxygenation can be improved by positive end expiratory pressure (PEEP) or pressure 
support. Effective technique and FeO
2
 monitoring can increase the effectiveness of pre-
oxygenation and thus increase the safety margin. Preoxygenation failures have to be 
identified and alternative oxygenation methods must be readily available in order to 
be applied quickly and easily. Although genetic and environmental factors play a role 
in diseases such as heart attack, stroke and cancer, which have become the cause of the 
worst death in the twenty-first century, the underlying problem in the development 
of these pathological conditions is hypoxia. Better understanding of hypoxic areas in 
ischemic tissues or growing tumors as well as increased knowledge of hypoxia cellular 
and molecular responses will allow possible applications in the treatment of major 
diseases associated with tissue hypoxia.
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1. Introduction
In this chapter, factors affecting the formation of severe hypoxemia during apnea, patho-
physiology of oxygen delivery and preoxygenation, pathophysiologic responses to hypox-
emia will be discussed.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In an anesthetized patient, oxygen consumption (VO
2
) remains fairly constant at 250 mL/min. 
This is delivered to the tissues by hemoglobin whose oxygen is then replenished, on return 
to the pulmonary circulation, by the diminishing store of oxygen within the lungs. Alveolar 
partial oxygen pressure (PAO
2
) is constantly reduced not only due to oxygen uptake by the 
lungs but also due to the severe negative intrathoracic pressure produced by this oxygen 
uptake, if the airway is occluded at the same time. However, the arterial partial pressure of 
oxygen (PaO
2
) drops directly to PAO
2
, while arterial hemoglobin oxygen saturation (SpO
2
) 
remains above 90% as long as hemoglobin can be oxygenated again in the lungs. SpO
2
 begins 
to fall only when the oxygen stores in the lungs are empty and PaO
2
 is 6–7 kPa. Their subse-
quent declines are constant and fast at around 30% per minute. At the beginning of this rapid 
decline, SpO
2
 is still around 90–95%. This bending point can be defined as “critical hypoxia.” 
Since oxymetry detects the fall in SpO
2
 before any obvious clinical sign, it has an important 
place in helping clinical applications to detect and avoid critical situations.
Preservation of oxygenation during intubation is essential because lack of control of O
2
 intake can 
cause life-threatening complications. Anesthesia induction usually leads to apnea. In this case, 
tissue oxygenation is maintained by the use of oxygen reserve and continuous O
2
 administration. 
In some cases, adequate oxygenation cannot be achieved due to pulmonary disease, inadequate 
mask ventilation or difficulties in intubation. These critical situations are often predictable and 
can be avoided by alternative oxygenation methods by following a valid algorithm [1].
2. Pathophysiology of oxygen delivery
Oxygenation during anesthesia mostly depends on three parameters: alveolar ventilation 
(VA), ventilation-perfusion distribution and VO
2.
2.1. Oxygen reserves
Tissue oxygenation during apnea is usually sustained at the expense of body O
2
 reserves that 
are present in the lungs, plasma, and hemoglobin [2]. When the ambient air is breathing, the 
lung O
2
 reserve is calculated as: 0.21 × 3000 = 630 mL for 3000 mL functional residual capacity 
(FRC). After full preoxygenation, FAO
2
 is close to 0.95 and the reserve increases as follows: 
0.95 × 3000 mL = 2850 mL. These theoretical figures are the maximum values; in practice, the 
rate of ventilation-perfusion is lower than that of FAO
2
 because of the heterogeneity. In a sub-
ject inhaling ambient air (PaO
2
 = 80 mmHg) and a plasma volume of 3 liters, plasma oxygen 
reserve is calculated as 0.003 × 80 × 3 × 10 = 7 mL. At 500 mmHg PaO
2
, this plasma reserve 
reaches 45 mL. The hemoglobin O
2
 reserve is calculated in the ambient air (SpO
2
 = 98%) for a 
hemoglobin concentration of 12 g/100 mL and a total blood volume of 5 L as follows: 1.34 × 
0.98 × 12 × 10 × 5 = 788 mL. This value increases to 804 mL for 1 FiO
2
 (SpO
2
 = 100%). In cases 
of anemia, hyperoxic ventilation increases the availability of O
2
 by replicating solute O
2
 [3]. 
Considering the basic physiological O
2
 reserves, while the ambient air is inhaled, the total O
2
 
reserve is approximately 1450 mL and reaches approximately 3700 mL in the pure O
2
 solution. 
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This increase (approximately 2250 mL) is mainly due to the rice FAO
2
 in FRC. Several factors 
influence O
2
 availability: the initial rise in PaCO
2
 (Haldane effect), FRC, FAO
2
, fraction of shunt, 
VO
2
, hemoglobin concentration, and cardiac output. Replacement of nitrogen by O
2
 in the lung 
reservoir during preoxygenation obeys an exponential law [2]. The change in O
2
 reserve over 
time is linear in both blood and tissue compartments.
2.2. O
2
 consumption
The VO
2
 value of an awake person is about 300 mL/min and falls about 15% in old aged people. 
After ventilation in ambient air, O
2
 reserves allow apnea for up to 3 minutes without serious eff 
on O
2
 transport. This time can be doubled with the correct applied preoxygenation. The duration 
of apnea tolerated is additionally decreased if O
2
 reserves are low due to decreased FRC, low 
PAO
2
 and/or high VO
2
 and the O
2
 reserves are reduced due to low FRC, PaO
2
 and/or high VO
2.
2.2.1. Ventilation/perfusion incompatibility
Preoxygenation leads to an increase in shunt and microatelectasis after induction of anesthe-
sia [4]. The inspired high O
2
 fraction (FiO
2
) is not the only responsible mechanism; atelectasis 
was also observed when FiO
2
 was used as 0.4 [5]. The use of 0.8 FiO
2
 does not inhibit the 
emergence of microatelectasis and results in a considerable shortening of the time limit before 
critical desaturation compared to the use of 100% oxygen [6]. Microatelectasis are reversible 
with alveolar engraftment (>30 cmH
2
O tracheal pressure for 15 seconds) and can be prevented 
by the addition of 10 cmH
2
O positive end expiratory pressure (PEEP) [7]. In morbidly obese 
patients and in parturients, shunt can exceed 20% and even increasing FiO
2
 to 1 does not pro-
vide correction of the hypoxemia. Implementation of a microatelectasis prevention strategy of 
alveolar recruitment maneuvers and PEEP limits the extent in elderly and obese patients [8, 9].
2.3. Epidemiology of arterial desaturation during anesthesia induction and 
intubation
Arterial O
2
 desaturation occurs if O
2
 reserves are insufficient to support O
2
 consumption during 
apnea. There are three responsible mechanisms: quantitative reduction in the reserve (decline 
in FRC, deterioration in gas exchange), VO
2
 increase (birth, fever), and prolonged apnea.
It is especially important to mention the four high-risk situations:
• Rapid induction sequence in which mask ventilation increases the risk of inhalation of 
gastric fluid.
• Prediction of difficult ventilation with face mask.
• Anatomical abnormality and prediction of difficult intubation with specific technical as-
sessments (such as double-lumen tube).
• Obesity and pregnancy.
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After rapid sequence induction, spontaneous ventilation reinitiation does not occur rapidly 
after an unsuccessful intubation procedure and saturation falls below 90% in 11% of patients 
[10]. Administration of succinylcholine (0.56 and 1 mg/kg) after induction with propofol 
(2 mg/kg) and fentanyl (μg/kg) has increased desaturation risk and apnea duration com-
pared to placebo [11]. In a pharmacodynamic study with succinylcholine (0.3–1 mg/kg), it 
found that the intubation conditions were excellent at doses above 0.5 mg/kg, but the delay 
in resumption of spontaneous breathing rose from 4.0 to 6.16 minutes after administra-
tion of 0.6 and 1 mg.kg−1, respectively [12]. Reversal of deep neuromuscular block (induced 
by high-dose rocuronium) with sugammadex (16 mg/kg) used for rapid sequence induc-
tion is significantly faster than spontaneous recovery of succinylcholine (6.2 ± 1.8 versus 
10.9 ± 2.4 minutes) [13]. Reversal with sugammadex following rapid sequence induction 
with rocuronium allows earlier restoration of spontaneous respiration compared to succi-
nylcholine (216 versus 406 seconds) [14]. Thus, the choice of the rocuronium would increase 
the margin of safety for a resumption of spontaneous ventilation after a rapid sequence 
induction.
2.3.1. Desaturation in pediatrics
Desaturation attacks occur frequently in children, with 4–10% during induction and 20% dur-
ing tracheal intubation [15]. Desaturation occurs faster if the child is younger [16, 17] and 
apnea duration in predesaturation has a linear relationship with the age of the patient. The 
low weight of the child increases the frequency of severe arterial desaturation. It is suggested 
that 95% SpO
2
 may be the safe apnea limit during induction of pediatric anesthesia [18]. It was 
noted that upper respiratory tract infection increased desaturation risk during induction [15]. 
The number of important factors effect the time from the onset of apnea to the development 
of critical hypoxemia.
2.3.1.1. Functional residual capacity (FRC)
FRC is the most important oxygen storage in the body. The larger the FRC, the longer apnea 
times can be preceded before the critical hypoxia develops. Alveolar oxygen fraction (FAO
2
) 
is around 13% in air breathing. For an adult with normal FRC and VO
2
, the oxygen content 
of the lungs (290 mL) will be consumed within 1 minute. This explains why you can expect 
a critical hypoxia after 1-minute apnea. Reduced FRC patients (lung disease, kyphoscoliosis, 
pregnancy, and obesity) reach critical hypoxia much faster.
2.3.1.2. Preoxygenation
Preoxygenation using a high FiO
2
 before anesthesia induction and tracheal intubation is par-
ticularly recommended in patients at risk for apneic arterial oxyhemoglobin desaturation. 
The success of preoxygenation to delay the onset of desaturation has been known for many 
years [19–21]. Preoxygenation during anesthesia induction is highly recommended in cases of 
desaturation prior to airway safety with endotracheal intubation. In situations where manual 
ventilation is not desired, such as patients with aspiration risk, preoxygenation has become 
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an integral component during rapid sequence induction/intubation [22–25]. It is also impor-
tant when difficulties associated with preoxygenation, ventilation, or tracheal intubation are 
predicted and the patient’s O
2
 reserves are limited [26, 27].
Guidelines developed by the Difficult Airway Society in the United Kingdom for unforeseen 
difficult intubation management in 2015 suggest that all patients must undergo preoxygen-
ation prior to induction of general anesthesia [28]. Residual effects of anesthetics or inad-
equate reversal of muscle relaxants can complicate emergence from anesthesia. These effects 
may result in decreased functional activity of the pharyngeal muscles, upper airway obstruc-
tion, effective cough insufficiency, a fivefold increase in aspiration risk, and hypoxic weakness 
controlled by peripheral chemoreceptors [29, 30]. Hypoventilation, hypoxemia and loss of 
airway may follow these changes. Preoxygenation can also minimize neostigmine-induced 
cardiac arrhythmias [31]. Considering the potential for airway and ventilation problems, 
“routine” preoxygenation is recommended before reversing neuromuscular blockage and 
before tracheal extubation [32]. The recommended guidelines for the management of tracheal 
extubation in 2012 by the Difficult Airway Society in the United Kingdom state that preoxy-
genation must be performed before extubation due to various perioperative anatomical and 
physiological changes that may put gas exchange in jeopardy [33]. Preoxygenation is also 
recommended before any ventilation interruption, such as open tracheobronchial aspiration.
3. Physiological basis, efficiency, and productivity
Preoxygenation increases the body O
2
 stores, the main increase occurring in the functional 
residual capacity. Accurate quantification of the increases in the O
2
 volume in various body 
tissues is difficult, but the estimated increases are notable when assuming that the partition 
coefficient for gases approximates the gas-water coefficients (Table 1, Figure 1) [2, 34].
The effectivity of preoxygenation is assessed by efficacy and efficiency. Efficacy indices include 
FAO
2
 increase, decreases in alveolar nitrogen fraction (FAN
2
), and increase in PaO
2
 [35–42]. The 
efficiency of preoxygenation is assessed by the decrease in oxyhemoglobin desaturation (SpO
2
) 
during apnea [10, 43, 44]. Preoxygenation increases FAO
2
 and decreases FAN
2
 (Figure 2) [45].
The key to achieve maximum preoxygenation is the excretion of alveolar nitrogen (N
2
). The 
terms preoxygenation and denitrogenation have been used synonymously to describe the 
Body store Room air 100% O
2
Lungs 450 3000
Blood 850 950
Dissolved in tissue fluids 50 100
Combined with myoglobin 200 200
Total 1550 4250
Table 1. Body O
2
 stores (in mL) during room air and 100% O
2
 breathing [34].
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same process. In a normal lung function case, filling with O
2
 and discharging of N
2
 are expo-
nential functions and are controlled by the time constant (t) of the exponential curves. This 
constant is proportional to the ratio of alveolar ventilation to functional residual capacity. 
Since preoxygenation prior to anesthetic induction is typically carried out using a semiclosed 
circular absorber cycle, the washout of the circuit must also be considered using the time con-
stant of the circuit, which is the time required for flow through a container (volume) to equal 
its capacity. Thus, there are two stages of preoxygenation (Table 2) [32]: washing the vessel 
with O
2
 flow and washing FRC by alveolar ventilation.
After 1 t, O
2
 at functional residual capacity is 63%; 2 t, then 86%; 3 t, then 95%; and after 
4 t, an increase of about 98% is observed. The endpoints of maximum preoxygenation and 
denitrogenation were defined as an end-tidal O
2
 concentration (EtO
2
) of about 90% and an 
Figure 1. Variation in the volume of O
2
 stored in the functional residual capacity (□), blood (▲), tissue (○), and whole 
body (◼) with the duration of preoxygenation [2].
Figure 2. Comparison of mean end-tidal O
2
 and N
2
 concentration obtained at 30 second intervals during 5-minute period 
of spontaneous tidal volume oxygenation using the circle absorber and Nasoral systems in 20 volunteers. Data are 
mean ± SD [45].
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after-tidal N
2
 concentration of 5% (EtN
2
) [2, 35]. In an adult subject with a normal functional 
residual capacity and oxygen consumption (VO
2
), an EtO
2
 > 90% implies that the lungs con-
tain >2000 mL of O
2
, which is 8–10 times the VO
2
 [26, 46]. Due to the presence of carbon diox-
ide (CO
2
) and water vapor in the alveolar air, it is thought that EtO
2
 > 94% cannot be obtained 
easily. Many factors affect efficacy and efficiency (Table 3).
Factors affecting the efficacy of preoxygenation are FiO
2
, duration of preoxygenation, and 
alveolar ventilation/functional residual capacity ratio. Failure to achieve a FiO
2
 of close to 
1.0 depends on the height of the ozone beneath the face mask, the rebreathing of exhala-
tion gases, and the high O
2
 dispersion of resuscitation bubbles [45, 48, 49]. FiO
2
 may also be 
affected by the duration of the aeration, the breathing technique, and the amount of fresh gas 
flow [50]. Bearded patients, toothless patients, elderly patients with sagging cheeks, facial 
mask use at the wrong size, and presence of gastric tubes (nasogastric) are common factors 
that cause air entrapment and a lower FiO
2
. The lack of a normal capnography wave and 
expected lower end-tidal CO
2
 concentration (EtCO
2
) and EtO
2
 should warn of the presence 
of leaks in the anesthetic cycle [26]. With a FiO
2
 close to 1.0, most healthy adults with tidal 
volume respiration can achieve an EtO
2
 > 90% target level within 3–5 minutes. The half-time 
for the exponential change in the FAO
2
 fraction following each unit change in FiO
2
 is given by 
the following equation:
  FAO 
2
  = 0.693 × Functional residual capacity / Volume of alveolar ventilation. 
Stage Description Determinant of t Recommendation
1 Washout of anesthesia circuit 
by O
2
 flow
Size of circuit/O
2
 flow 
rate
Washout of circuit by high O
2
 flow before placing 
face mask
2 Washout of FRC by VA FRC/VA Use of O
2
 flow rate that eliminates rebreathing
FRC, functional residual capacity; t, time required for flow through a container (volume) to equal its capacity; and VA, 
alveolar ventilation [32].
Table 2. Stages of preoxygenation.
Efficacy
• Inspired oxygen concentration
• Presence of leak anesthetic system used level of FGF
• Type of breathing (tidal volume or deep breathing) and duration of breathing
• VA/FRC ratio
Efficiency
• Oxygen volume in lungs (alveolar oxygen tension, FRC)
• Systemic oxygen supply versus demand balance (arterial oxygen content, cardiac output, whole body oxygen 
consumption)
FGF, fresh gas flow; FRC, functional residual capacity; and VA, alveolar ventilation [32].
Table 3. Factors affecting the efficacy and efficiency of preoxygenation.
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With a functional residual capacity of 2.5 L, the half-times are 26 seconds when alveolar venti-
lation = 4 L/minutes and 13 seconds when alveolar ventilation = 8 L/minutes [26]. These find-
ings indicate that hyperventilation can reduce the time required to increase the O
2
 stores in 
the lungs, which provides the basis for using deep breathing as an alternative to tidal volume 
breathing [41, 42, 51, 52].
3.1. Preoxygenation techniques
Equipment especially face mask should be adapted and it should fit the patient. Mask and 
stylistic mismatch between the patient’s face (mask improper length, beards, or mustaches 
asset) can prevent the complete closure and lead to failure [35]. The mask must be applied 
securely on the face of the patient; 20% dilution of O
2
 by ambient air occurs when the mask is 
not tightly applied and 40% dilution occurs when it is held close to the face. The mask should 
be applied firmly to the patient’s face; when the mask is not fully seated, dilution of up to 20% 
with ambient air in O
2
 and 40% dilution when held close to the face appear [53]. The circle 
system with fresh gas flow (5 L/minutes) is used as the standard for comparison in anesthesia 
studies evaluating the effectiveness of different circuits because it allows higher inspiratory 
flow rates. Some open circuit systems (Bain or Magill) have been shown to be much less 
efficient [54]. Before preoxygenation, the circuit and reservoir must be filled with O
2
. Three 
preoxygenation techniques are used: spontaneous breathing at FiO
2
 of 1 for 2–5 minutes, the 
“four vital capacities” method, and deep breaths.
3.1.1. Spontaneous breathing at FiO
2
 of 1
This preoxygenation technique, first proposed by Hamilton in 1955, is still the reference stan-
dard: 3 -minute spontaneous breathing at FiO
2
 of 1 level. In patients with normal lung func-
tion, this leads to denitrogenation with FAO
2
 approaching 95%. Denitrogenation is effective 
from the first minute of preoxygenation; however, delay these effects with a rapid decline in 
the fugitive FiO
2
 on the run [55]. Although pure O
2
 breathing for longer than 1 minute seems it 
may have little SpO
2
 or denitrogenation benefit, it has positive effect on apnea duration before 
desaturation [51]. In experiments with healthy subjects, the duration of the apnea can be as 
long as 10 minutes after the 3-minute classic preoxygenation. The apnea time can be increased 
by an additional 2 minutes by application of positive pressure during the preoxygenation and 
by ventilation to the mask after induction [56].
3.1.2. Vital capacity maneuvers
The four vital capacity method is used in cases where the patient cannot cooperate, and the 
duration of apnea without desaturation is shorter after four capacity maneuvers than with 
spontaneous breathing. Technical requirements are responsible for the limitations of this 
technic: bag capacity, inspiratory flow, and room gas inspiration. These problems are par-
tially solved with an additional 2-liter bag and a non-rebreathing ambu valve. Vital capacity 
maneuver begins with forced expiration to optimize FeO
2
 increase [57]. To be fully effective, 
the inspiratory O
2
 flow should be greater than the peak inspiratory flow, which is attained by 
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activating the O
2
 system “by-pass” during inspiration; 4 or 5 forced breaths of pure O
2
 were 
found to be as efficient as conventional preoxygenation assessed on the FeO
2
 [58]. However, 
these results were not verified when using PaO
2
 for comparison. After four vital capacity 
maneuvers, it is observed that PaO
2
 (293 ± 86 mmHg) is lower compared to after spontaneous 
ventilation in pure oxygen (397 ± 48 mmHg) [59].
3.1.3. Deep breathing method
Eight deep breaths at a constant oxygen flow of 10 mL/min in a 60-second period create a sim-
ple method for preoxygenation. This technique results in an average arterial oxygen pressure 
of 369 ± 69 mmHg, which is not significantly different from the value achieved by 3 minutes 
of tidal volume breathing at an oxygen flow of 5 L per minute [42]. It has been argued that the 
voluntary hyperventilation technique (1 minute in FiO
2
 followed by voluntary hyperventila-
tion for 2 minutes) prevents postapneic hypercapnia. Postintubation PaCO
2
 was similar when 
preinduction hyperventilation was used as preoxygenation technique or normal respiration 
was used for 3 minutes [60].
3.1.4. Pressure-assisted ventilation (PSV)
In healthy volunteers, PSV has been shown to improve preoxygenation quality by two 
mechanisms: accelerate nitrogen excretion and provide better contact between mask and 
face. In a study of healthy volunteers, the mean expired fraction of O
2
 (FeO
2
) after 3 min-
utes of preoxygenation was higher (p < 0.001) with 4 cmH
2
O (94 ± 3%) PSV/PEEP and 
6 cmH
2
O PSV/PEEP (94 ± 4%) [61]. Increasing fresh gas flow (FGF) between 5 and 10 L 
during deep breathing does not provide a significant increase in FiO
2
 value during tidal 
volume breathing [50]. Due to the breathing properties of the circulator system, the min-
ute ventilation during deep breathing can exceed the FGF, causing a reincrease in N
2
 in 
the exhalation gases and therefore lower FiO
2
. However, regeneration of N
2
 in exhalation 
gases during tidal volume breathing is insignificant, and thus increasing FGF by 5–10 L 
has minimal effect on FiO
2
 [50].
All investigations have demonstrated that preoxygenation markedly delays arterial oxyhe-
moglobin desaturation during apnea. [26, 36, 38, 43]. The extent of this delay in desaturation 
depends on the efficacy of preoxygenation, the capacity for O
2
 loading, and the VO
2
 [47]. 
Patients with a decreased capacity for O
2
 transport (decreased functional residual capacity, 
PaO
2
, arterial O
2
 content, or cardiac output) or those with an increased VO
2
 develop oxyhemo-
globin desaturation more rapidly during apnea than healthy patients [26, 43].
Farmery and Roe developed and validated a computer model describing the rate of oxyhe-
moglobin desaturation during apnea [62]. The model is particularly useful for analyzing oxy-
hemoglobin desaturation values below 90%. These values are dangerous to allow in human 
subjects because below 90%, there will be a steep decline of PaO
2
 due to the sigmoid shape 
of oxyhemoglobin dissociation curve. In a healthy 70 kg patient, when FaO
2
 is progressively 
decreased from 0.87 (FiO
2
 of 1.0) to 0.13 (air), the apnea time to 60% SaO
2
 is decreased from 
9.9 to 2.8 minutes (Figure 3) [43].
Pathophysiology of Apnea, Hypoxia, and Preoxygenation
http://dx.doi.org/10.5772/intechopen.76851
31
Regardless of the technique used, the goal is to reach the end of maximal preoxygenation, 
which can easily be measured by most anesthesia monitors.
3.2. Preoxygenation for high-risk patient population
3.2.1. Pregnant patients
Rapid sequence induction/intubation is often used in pregnancies given general anes-
thesia and preoxygenation is important in these patients. Maximum preoxygenation can 
be achieved faster in pregnant women than in nonpregnant women due to higher alveo-
lar ventilation and lower functional residual capacity [37, 63]. However, oxyhemoglobin 
desaturation in pregnant women during apnea develops more rapidly because they are 
associated with a limited O
2
 volume and increased VO
2
 in their less functional residual 
capacities. During the apnea, the time required for SaO
2
 to fall to 95% was 173 seconds 
for pregnant women and 243 seconds for women who were not pregnant in the supine 
position [64].
Using the 45° head up position causes an increase in the desaturation duration in nonpreg-
nant women, but it is not seen in pregnant women. The size of the uterus may prevent the 
descent of the diaphragm and may not allow the expected increase in functional residual 
capacity in the head-up position [64]. Four deep breathing techniques in pregnant women 
are below the 3-minute tidal volume breathing technique and should not be used except in 
emergencies [65]. Increased minute ventilation in pregnant women requires the use of an O
2
 
flow of 10 L/minutes during preoxygenation [66].
Figure 3. Arterial oxyhemoglobin saturation (SpO
2
) versus time of apnea in an obese adult, a 10 kg child with low 
functional residual capacity and high ventilation, and a moderately ill adult compared with a healthy adult. FaO
2
 
indicates fractional alveolar oxygen concentration; VE, expired volume [43].
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3.2.2. Morbid obesity patients
Studies have demonstrated that following preoxygenation with tidal volume breathing for 
3 minutes, the time required for SaO
2
 to fall to 90% during apnea is markedly reduced in mor-
bidly obese patients (BMI > 40 kg/m2) compared with nonobese patients [67, 68]. During apnea 
after preoxygenation, the mean time to reach 90% of SaO
2
 in normal body weight patients 
was 6 minutes, while in morbid obese patients it was 2.7 minutes [69]. Rapid oxyhemoglobin 
desaturation during apnea in morbidly obese patients was attributed to an increased VO
2
 and 
a markedly reduced FRC.
Spontaneous respiration and effectiveness of eight deep breaths as preoxygenation method 
are similar in obese patients with previous apnea before reaching 95% of FeO
2
 and SpO
2
 
[70]. Continuous positive airway pressure (CPAP) (7.5 cmH
2
O versus Mapleson circuit) dur-
ing spontaneous ventilation in pure O
2
 was observed not to improve the duration of apnea 
(240 and 203 seconds CPAP versus zero end expiratory pressure, respectively) [71]. PaO
2
 
improved significantly after intubation when PEEP and PSV applied together after CPAP [72]. 
PSV improves preoxygenation quality, possibly by increasing alveolar circulation in obese 
patients [73]. Compared to 5 minutes of spontaneous ventilation with FiO
2
 of 1, PSV results 
in increased FeO
2
 (96.9 ± 1.3% versus 94.1 ± 2.0%) and acceleration of nitrogen elimination 
(185.3 ± 46.1 versus 221 ± 41.5 s) [74]. When combined with recruitment maneuvers, PSV 
activity has statistical significance in terms of arterial oxygenation [75]. In morbidly obese 
patients, preoxygenation resulted in better oxygenation compared to 5 cmH
2
O CPAP neutral 
pressure breathing combined with 5 cmH
2
O PSV and prevented desaturation episodes [76]. 
Postintubation PaO
2
 was significantly higher in the CPAP/PSV group (32.2 ± 4.1 kPa) than in 
the control group (23.8 ± 8.8 kPa) (p < 0.001). Lower oxygen saturation was lower in the control 
group (median 98%, range, 83–99%) than the CPAP/PSV group.
The supine position reduces the functional residual capacity due to the upward displacement 
of the diaphragm. It has been shown that placement of severe obese patients in the 25° up posi-
tion during preoxygenation prolongs the desaturation time [77]. Some anesthetists may prefer 
awake fiberoptic intubation instead of rapid sequence induction/intubation in morbid and super 
morbid obese patients (BMI > 50 kg/m2), especially when they have associated problems [78].
3.2.3. Pediatric patients
Respiratory physiology of young children is age-specific. The inhibition of intercostal tone 
with general anesthesia is responsible for the reduction in FRC. Hypoxia occurs more rap-
idly in children due to higher VA/FRC ratio, higher O
2
 consumption and lower O
2
 reserves. 
Children exhibit a delay of approximately 80–90 seconds before reaching FeO
2
 values close to 
90% when breathing at FiO
2
 of 1 level [79]. After a period of at least 2 minutes breathing at FiO
2
 
of 1 and after muscle paralysis, the duration of apnea before the SpO
2
 reaches 90% is found 
to be 96.5 seconds in children less than 6 months of age, 160.4 seconds in 2–5 year olds, and 
382.4 seconds in 11–18 year olds [80]. In children younger than 6 months, even shorter apnea 
time limits, on the order of 70–90 seconds have been reported [16]. The duration of apnea 
required to reach a SpO
2
 of 98, 95, or 90% is significantly increased when the preoxygenation 
is extended for 1–2 minutes, but no benefit was found by extension past 3 minutes [18].
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Studies have shown that maximal preoxygenation (EtO
2
 = 90%) can be achieved in children 
faster than in adults [79, 81]. With tidal volume respiration, almost all children can reach 90% 
EtO
2
 within 100 seconds, whereas it can be reached within 30 seconds by deep breathing [79, 81]. 
However, since children have a lower functional residual capacity and a higher VO
2
 than adults, 
they may be at a greater risk of developing hypoxia when interruption of O
2
 transport occurs, 
such as during apnea or airway obstruction [82–84]. In a comparison of three groups of children 
who breathed O
2
 (FlO
2
 = 1.0) with tidal volume breathing for 1, 2, and 3 minutes before apnea, 
the time needed for SaO
2
 to decrease from 100 to 95% and then to 90% during apnea was least 
in those who breathed O
2
 for 1 minute and there was no difference between those who breathed 
O
2
 for 2 and 3 minutes [85]. Based on these findings, 2 minutes of preoxygenation with tidal vol-
ume respiration seems to be sufficient to provide a maximum benefit and a safe apnea period 
[85]. The advantage of preoxygenation is greater in a larger child than in a baby. For example, 
in an 8-year-old child, the duration of the apnea-safe period may be extended to 5 minutes or 
longer with preoxygenation, whereas the duration is 0.47 minutes without preoxygenation [86]. 
The smaller the child, the faster the start of desaturation [80, 83, 84]. After the onset of apnea, 
most infants reach 90% SpO
2
 within 70–90 seconds (despite preoxygenation) and this time may 
be shorter in the presence of upper respiratory tract infection [16, 87]. Pediatric anesthesiologists 
expressed concern about the use of the “adult” version of the rapid sequence induction/intuba-
tion technique in children [88]. Concerns include the safe duration of apnea and the potential for 
airway obstruction induced by cricoid compression. A modified version of the rapid sequence 
induction/intubation technique appears to be more appropriate for children with emphasis on 
full muscle relaxation and gentle manual ventilation using high O
2
 concentration with adequate 
anesthesia depth without cricoid pressure before intubation [89].
3.2.4. Elderly patients
Old age is associated with significant structural and physiological changes in the respiratory 
system [90, 91]. The changes also include a reduction in elastic recoil with weakened respira-
tory muscles and parenchymal changes in the lungs. Lung volumes are reduced by increased 
closure volume, which causes ventilation-perfusion mismatch, reduced pulmonary reserve, 
and impaired oxygen uptake in the lung. While basal VO
2
 declines with aging, impaired O
2
 
intake creates a faster desaturation during apnea under anesthesia [91]. In elderly patients, 
tidal volume breathing of 3 minutes or longer has been shown to be more effective than four 
deep breathing techniques [92, 93].
3.2.5. Patients with lung diseases
Severe pulmonary disease is associated with decreased FRC, increased ventilation-perfusion 
incompatibility, and increased VO
2
, which can reduce the safety margin. Anesthesia has been 
shown to cause further deterioration of gas exchange in patients with chronic obstructive pul-
monary disease [94]. As well as in aspiration, even short ventilation interruptions can cause 
desaturation. Besides, atelectasis is not a consequence, presumably the chronic hyperinflation 
of the lungs resists volume decline and collapse [95]. For maximum preoxygenation in these 
patients, 5 minutes or more may be needed with tidal volume breathing [96].
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3.2.6. Patients in high altitude
High altitude does not shift inhaled O
2
 concentration but reduced barometric pressure causes 
in a decrease partial alveolar pressure and arterial PO
2
 [97]. As altitude increases, PaO
2
 
decreases exponentially. Patients at high altitudes may need longer lasting preoxygenation.
3.3. Techniques to improve preoxygenation
3.3.1. Apneic diffusion oxygenation
Following preoxygenation, “apneic diffusion oxygenation” is an effective maneuver that pro-
longs the safe duration of apnea [32, 98–102]. The physiological basis of this maneuver is: In 
adults, VO
2
 averages are 230 mL/min during apnea, whereas CO
2
 delivery to alveoles is only 
21 mL/min [32]. The remaining 90% (or more) of CO
2
 is buffered in body tissues. As a result, O
2
 
enters the lung by diffusion, provided that the lung volume initially decreases by 209 mL/min 
and forms a pressure gradient between the upper airway and the alveoli, and the airway is not 
obstructed. If CO
2
 cannot be excreted, PaCO
2
 increases to 8–16 mmHg for the first minute of 
apnea followed by a linear increase of about 3 mmHg/min [103]. The advantage of apneic dif-
fusion oxygenation depends on reaching the maximum preoxygenation before apnea, remain-
ing open in the respiratory tract, and is on the presence of high FRC relative to body weight. 
Although the drop in PaO
2
 is directly related to PaO
2
, SpO
2
 remains greater than 90% as long 
as the hemoglobin is oxygenated again in the lungs [46, 99, 100, 104]. SpO
2
 decreases only after 
the O
2
 stores in the lungs are exhausted, and PaO
2
 falls below 60 mmHg. When SpO
2
 becomes 
<80%, the saturation reduction rate is approximately 30%/min. In the presence of an airway 
obstruction, the volume of gas in the lungs decreases rapidly and the intrathoracic pressure 
decreases with respect to lung compliance and VO
2
. When airway obstruction is relieved, a 
rapid O
2
 flow begins in the lungs and preoxygenation with high FiO
2
 improves [46]. Some 
studies have shown that through an open air pathway, apneic diffusion oxygenation can keep 
the SpO
2
 value above 90% for up to 100 minutes [99, 100]. When FiO
2
 is at a high level, a small 
increase can cause a fairly disproportionate delay in hemoglobin desaturation. The delay in 
hemoglobin desaturation obtained by FiO
2
’s raising from 0.9 to 1.0 was above that obtained by 
FiO
2
’s raising from 0.21 to 0.9 (Figure 4) [105].
Apneic diffusion oxygenation can be achieved with maximum face mask preoxygenation fol-
lowing O
2
 insufflation to 15 L/minutes via a nasopharyngeal or an oropharyngeal cannula or 
a needle inserted into the cricothyroid membrane. In healthy patients with a healthy airway, 
this technique can provide adequate oxygenation for at least 10 minutes. Although oxygen-
ation can be maintained for a longer period of time, a limiting factor of apneic oxygenation is 
the gradual rise of PaCO
2
 during apnea [103].
3.3.2. Continuous positive airway pressure (CPAP) and positive expiratory pressure (PEEP)
The CPAP usage in the preoxygenation delayed the desaturation period by mechanical venti-
lation using positive end expiratory pressure (PEEP) for 5 minutes before removing the mask 
and securing the airway [106, 107].
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3.3.3. Noninvasive bilevel positive airway pressure (BİPAP)
BiPAP combines pressure-assisted ventilation (PSV) and CPAP advantages and keeps the 
lungs open during the respiratory cycle. BiPAP has been used during preoxygenation to 
decrease intrapulmonary shunting and to increase the margin of safety during apnea in mor-
bidly obese patients [108]. This technique is also used to reduce postoperative pulmonary 
dysfunction and to treat patients with respiratory insufficiency from various etiologies [109].
3.3.4. Transnasal humidified rapid insufflation ventilatory exchange (THRIVE)
THRIVE is a new technique that is available for use in critically ill patients and in patients 
with difficult airways. The technique combines the benefits of apneic oxygenation and CPAP 
with a reduction in CO
2
 levels through gaseous mixing and flushing of the dead space [110]. 
THRIVE is used as standard with a nasal, high flow oxygen delivery system, as sold in the 
market. The THRIVE technique has been shown to significantly prolong the period of apnea 
safety while avoiding CO
2
 increase [111].
3.4. Potential risks of the preoxygenation
• Delay in the diagnosis of the esophageal intubation.
• Absorption atelectasis.
• Production of reactive oxygen radicals.
• Cardio-cerebrovascular responses.
It causes a decrease in heart rate and cardiac output. Systemic vascular resistance and arterial 
blood pressure increase [112–114]. These changes are detected by chemoreceptors or barore-
ceptors. Direct coronary vasoconstrictor effect of hyperoxia is due to oxidative inactivation of 
nitric oxide and other vasodilators released by vasculature [115–117]; it reaches up to collapse 
Figure 4. The time (duration of apnea) required to reach 50% SaO
2
 with an open airway exposed to various ambient O
2
 
fractions [105].
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of the endothelin and K+ channels sensitive to ATP [118, 119]. It is well known that high O
2
 
inhalation may reduce cerebral blood flow due to vasoconstriction [120–123]. It has been pro-
posed that this effect may be because, at least in part, of the associated decrease in PaCO
2
 that 
accompanies high O
2
 breathing rather than to a direct effect of O
2
 [121]. The decline mecha-
nism in the PaCO
2
 is that: When PaO
2
 is increased by 100% O
2
 inhalation, the CO
2
 dissociation 
curve for blood changes (Christiansen-Douglas-Haldane effect), thus CO
2
 affinity for blood is 
reduced. This causes an increase in the cerebral tissue PCO
2
 and hydrogen ion concentration, 
which stimulate respiration that causes cerebral vasoconstriction with a decrease in PaCO
2
 
[122, 123]. Researchers assessed the effect of hyperoxia on cerebral oxygen consumption using 
a functional magnetic resonance technique and found that hyperoxia caused a reduction of 
about 20% in cerebral O
2
 consumption and decreased neuronal activity [122]. The reduction in 
cerebral O
2
 consumption is thought to be due to the fact that reactive oxygen radicals damage 
lipids and proteins and reduce enzyme activity in the oxidative metabolic pathways. Studies 
in animal models have shown that hyperoxia causes vasoconstriction and causes a decrease 
in blood circulation in the peripheral vascular beds, including the kidney and gastrointestinal 
tract [120, 124, 125]. However, it is doubtful that changes in peripheral vascular beds will have 
any significant clinical effect during preoxygenation. So far, cardiovascular findings do not 
provide any justification for limiting the use of preoxygenation.
4. Maintenance of a patent airway
There is a dynamical balance between O
2
 and CO
2
 during breathing. The volume of CO
2
 pass-
ing from the pulmonary circulation to the alveolar space is 80% of the oxygen volume mov-
ing in the reverse direction. This changes radically at the onset of apnea. During apnea, the 
rate of oxygen extraction from the alveoli remains at 250 mL/min without being affected. The 
amount of CO
2
 entering the alveoli is very low. The reason is that CO
2
 is more water soluble 
than oxygen. For this reason, only 10% of the CO
2
 produced per minute (about 20 mL) reaches 
the alveolar space. The remaining 90% remain molten in the textures. Therefore, the volume 
of gas in the lungs decreases rapidly during apnea, and if the airway becomes clogged, intra-
thoracic pressure decreases due to oxygen consumption and thoracic compliance. The closed 
airway apex begins with an intrathoracic pressure equal to or slightly greater than the ambient 
pressure. Oxygen uptake causes by an almost subatmospheric intrathoracic pressure. During 
long-standing apnea, the intrathoracic pressure may be much lower than the environmental 
pressure, and the alveolar partial pressure of oxygen is significantly dangerously reduced. An 
open airway will allow oxygen to spread to the apneic lung. Providing an open airway and 
exposing 100% oxygen creates “apneic mass movement oxygenation,” which has been shown 
to provide oxygen saturation for up to 100 minutes in animal and simulated human studies. If 
the denitrogenesis of the alveolar space is as complete as possible and a tight compliance mask 
is used, this passive diffusion of oxygen is more effective. It is important to provide a very high 
oxygen fraction FiO
2
 in order to extend the safety time of the apnea; increasing the oxygen 
fraction applied to the respiratory tract from 90 to 100% doubles critical hypoxia time with 
open air [126]. Increasing the FiO
2
 applied to the airway from 21 to 90% has a much greater 
effect on the critical hypoxia time. In a patient with an apnea, 100% oxygen administration to 
the patent airway will delay the onset of critical hypoxia, but this approach will not reverse the 
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hypoxemia that is currently developing. Moreover, after a while, it does not prevent continu-
ous development of hypercapnia, which is life threatening and acidosis related to hypercapnia.
5. Reoxygenation
When airway obstruction is relieved during apnea, there is a flow of gas through the pres-
sureless thorax. Securing a high FiO
2
 during this one passive inhalation saves time to save the 
airway. Securing a high FiO
2
 during this one-time passive inhalation may lead to a significant 
prolongation of the duration of the apnea. If airway obstruction is relieved with 100% oxygen, 
the patient is likely to have a temporary improvement in hemoglobin oxygen desaturation, 
even though the tidal volume is not maintained and inspired oxygen volume is small.
6. Hemoglobin concentration
The prominence of hemoglobin is not that it is an oxygen storage but it is an efficient oxygen 
transport from the lungs to the tissues. Anemia causes a small decrease in the time of critical 
hypoxia; however, this effect will also be more pronounced in patients with reduced FRC.
7. Metabolic rate
Metabolic rate has a simple and predictable effect on the rate of oxygen uptake and hence 
the duration of critical hypoxia. Increasing the oxygen consumption from 250 to 400 mL/min 
reduces the time for SpO
2
 to increase from 40 to 50% [126].
8. Physiological shunt and dead space
The venous shunt reduces the PaO
2
 and SpO
2
 foreseeably, but severe hypoxemia develops 
when the accessible oxygen stores are exhausted. However, many patients with venous shunts 
also have a reduced FRC (e.g., pulmonary edema), which will accelerate the onset of hypoxia.
8.1. Physiopathological responses to hypoxia
Heart attacks, stroke, and cancer have become the most common causes of death in the 
twenty-first century, as the average age in many countries around the world is constantly 
increasing. The causes of these diseases are many and varied; it indicates genetic predisposi-
tion and environmental effects. But limited oxygen is a common feature that is contributing to 
the development of these pathological conditions all around. However, cells and organisms 
can trigger adaptive responses aimed at helping them cope with these threats to hypoxic con-
ditions. Under this heading, the role of hypoxin in three pathological conditions consisting 
of myocardial, cerebral ischemia, and tumorigenesis will be briefly explained. The ability to 
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sustain oxygen homeostasis is crucial for survival of all vertebrate species. For the O
2
 presen-
tation, correct forming of complex platform such as entry (lungs), transport vehicles (eryth-
rocytes), motorways and secondary roads (vasculature), and repulsive force (heart) during 
development and regulations in organism entry form the basis for oxygen homeostasis.
8.2. Physiological responses to hypoxia
8.2.1. Systemic responses
Hypoxia and hyperoxia are detected by specialized chemoreceptor cells. In cases where the 
use of O
2
 is impaired, chemoreceptor systems rapidly change blood circulation as well as 
pulmonary ventilation and perfusion to optimize O
2
 delivery to tissues. This process is based 
on the direct response of the neuroepithelial bodies present in the airway to the specialized 
chemoreceptor cells, such as arterial circulation carotid bodies, and the hypoxia of vascular 
smooth muscle cells.
8.2.2. Vascular smooth muscle cells
While the peripheral vein are enlarged in response to low oxygen, the veins in the pulmonary 
vein narrows in order to achieve ventilation-perfusion matching by removing blood from areas 
where ventilation is worse [127]. Hypoxic pulmonary vasoconstriction is a rapid response in 
the pulmonary arteries and venules. It is abundant in small resistance arteries. Pulmonary 
vein is an intrinsic feature of the vein smooth muscles and begins with the inhibition of one or 
several of the various K+ channels that regulate the membrane potential [128]. The resulting 
depolarization activates voltage-gated Ca+2 channels, and activation of the channels increases 
the systolic calcium level and leads to myocyte constriction (Figure 5A). While K+ channels are 
the effects of hypoxic pulmonary vasoconstriction, it does not known that whether they are 
intrinsically O
2
-sensitive or under the control of an actual O
2
 receptor. Hypoxic vasodilatation 
is another rapid response that increases blood perfusion in O
2
-deprived tissues. This is espe-
cially indicated in coronary and cerebral vessels. Hypoxic vasodilation is mediated in part by 
K-ATP channels opened in response to hypoxia-induced ATP reduction in vascular smooth 
muscle cells (Figure 5B) [129].
Figure 5. Schematic representation of the response of vascular smooth muscle cells to hypoxia. (A) Pulmonary smooth 
muscle cells and (B) peripheral smooth muscle cells [129].
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However, there are other O
2
-sensitive mechanisms that most likely function by regulating the 
entry of Ca+2 into the cell.
8.2.3. Carotid and neuroepithelial bodies
Airway neuroepithelial bodies perceive changes in oxygen inspired, while carotid objects per-
ceive arterial oxygen levels. Both of them respond to low O
2
 presentation by initiating activity 
in efferent chemosensory fibers to form cardiorespiratory regimens in the event of low O
2
 
[130, 131].
The induction activity of chemoreceptor cells by hypoxia/hypoxemia is dependent on 
the presence of membrane K+ channels inhibited by low O
2
. As a result, increased cyto-
solic calcium concentration causes activation of neurotransmitter release and efferent 
sensory fibers.
8.2.4. Regulation of the cellular metabolism
One of the most essential parameters that healthy cells have to maintain is high ATP content. 
Cell death occurs when the ATP production does not meet the energy required to sustain the 
ionic and osmotic balance. When ATP levels fall, ion-motivated ATPase regeneration occurs, 
leading to membrane depolarization, Ca+2 flow into the cell from voltage-gated Ca+2 channels, 
and subsequent activation of calcium-dependent phospholipases and proteases. These events 
result in uncontrolled cell swelling, hydrolysis of the major cell components, and eventual cell 
necrosis (Figure 6) [132].
8.2.5. Effects of hypoxia on mitochondria
Oxygen deprivation is generally considered mitochondrial respiratory failure in the case of 
hypoxia or ischemia. In fact, mitochondria are the main source of molecules with high-energy 
Figure 6. Schematic representation of the cascade leading to cell death when cells are exposed to severe hypoxia [132].
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phosphate bonds in normal cells. Electron transport into O
2
 in the oxidation of NADH and 
FADH
2
 is tightly bound by ATP synthesis. Electron transport is carried out via protein-bound 
redox centers to complex III then (Co-enzyme Q-cytochrome c reductase) and complex IV 
from complex I (NADH-coenzyme Q reductase) or II (succinate-coenzyme Q reductase) and 
forms an electrochemical H + gradient in the inner membrane of the mitochondria. This gradi-
ent is used for ATP synthesis by complex V (ATP synthase) after electrochemical gradient: this 
process is known as oxidative phosphorylation.
Studies on isolated mitochondria have shown that the basic effect of decreasing O
2
 on mito-
chondrial respiration is inhibition in the respiratory chain and increase in proton leakiness 
while phosphorylation is less affected [133, 134].
8.2.6. Adaptation to hypoxia
Hypoxia adaptation at the cellular level is accomplished by increasing the efficiency of the 
energy-producing pathways in a basically increased anaerobic glycolysis activity, while 
reducing energy consuming processes [135]. Ion-motive ATPase and protein synthesis are 
predominant processes in energy consumption in cells at standard metabolic rate, produc-
ing over 90% of ATP consumption in mouse skeleton and 66% in mouse thyocytes [136]. 
Hepatocyte studies have shown that protein synthesis is largely inhibited in response to 
hypoxia [137]. Buttgereit and Brand [138] have shown that ATP-consuming processes are in 
fact organized in a hierarchy, protein synthesis and RNA/DNA synthesis are the first inhibi-
tory processes when energy becomes limited, and Na/K pump and Ca cycle have the highest 
priority. This phenomenon, also known as oxygen adaptation, involves very precise regula-
tory mechanisms at the level of translation initiation [139].
Hypoxic cells turn to glycolysis to meet energy needs. Oxygen-dependent mitochondrial 
respiration from two pathways of ATP production lowers oxygenation than oxidative phos-
phorylation in oxygen-independent glycolytic ATP production. In the presence of sufficient 
glucose, glycolysis may continue to produce ATP, depending on the increased activity of gly-
colytic enzymes. Phosphofructokinase is the major regulator that controls carbon flux by gly-
colysis. It is allosterically activated by ADP and AMP and inhibited by ATP; in this way, the 
rate of glycolysis is regulated according to the energy requirement. However, the most potent 
allosteric activator is fructose-2, 6-biphosphate [140]. The synthesis and degradation of the 
fructose-2, 6-biphosphatase are dependent on a single enzyme (6-phosphofluoro-2-kinase/
fructose-2, 6-biphosphate [PFK-2]). This enzyme is regulated within minutes by phosphoryla-
tion via AMP-activated protein kinase (AMPK) [141], but the expression is also enhanced by 
transcriptional activation via hypoxia-induced factor-1 (HIF-1) [142]. AMPK phosphorylates 
PFK-2 in a single site resulting in an increase in the Vmax of kinase activity, thus the allosteric 
activation of phosphofructokinase enhances.
The active kinase opens the ATP-producing catabolic pathways and closes the ATP-consuming 
anabolic pathways [143, 144]. This acute direct phosphorylation is chronically provided by 
gene expression. Phosphorylation of PFK-2 is an example of this. AMPK activation has been 
reported to transport glucose-transporter Glut-4 to the plasma membrane, resulting in glu-
cose uptake. Glut-4 increases the expression of mitochondrial enzymes that play a role in the 
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long-term hexokinase and tricarboxylic acid cycle and in the respiratory chain. On the other 
hand, AMPK directly inhibits the expression of fatty acid, triglyceride, and sterol synthase 
and the expression of fatty acid synthase and gluconeogenesis enzymes [145].
8.2.7. Regulation of the gene expression
When faced with hypoxic difficulties, various responses are developed by cells and tissues:
• Increased ventilation and heart rate
• Return from aerobic metabolism to anaerobic metabolism
• Promotion of increased vascularization
• Strengthening the O
2
 transport capacity of blood.
Most of these processes take place very early with the onset of hypoxia and are caused by the 
activation of existing proteins; but in the long run, all of these responses are mediated by the 
upregulation of genes encoding key actors, for example:
• Tyrosine hydroxylase, which plays a role in dopamine synthesis in carotid body type I cells.
• Glycolytic enzymes phosphoglycerate kinase 1, pyruvate kinase m, phosphofructokinase, 
aldolase A, glyceraldehyde 3-phosphate dehydrogenase enolase 1, and glucose carriers 
Glut-1 and Glut-4.
• VEGF and PDGF to induce angiogenesis and NO synthase that increases vasodilatation
• Transferrin receptors supporting erythrocyte production [146]. The transcriptional side is 
largely mediated by the HIF-1 activity.
HIF-1 is a heterodimeric factor consisting of HIF-1α and HIF-1β/ARNT. Both subunits belong 
to the Per-ARNT/Ahr-Sim family of bHLH transcription factors. While the HLH and PAS 
motifs play a role in dimerization, the main coil is the DNA-binding site. The HIF-1 [alpha] 
protein contains two transactivation regions at the C-terminus. ARNT is structurally expressed 
and is located in the nucleus. On the other hand, hypoxia accumulates when HIF-1α mRNA 
levels are constant in normoxia and hypoxia, and normoxide protein is rapidly destroyed. 
Normoxide targets the HIF-1α polyubiquitin and destroys the protozoa. In addition to the 
reduction of hypoxic synthesis of all proteins, ARNT and HIF-1α proteins are translocated 
efficiently due to the presence of the internal ribosome entry in the mRNA corresponding to 
the normoxia and hypoxia and normoxside [147].
HIF-1α contains an oxygen-dependent degradation site in which a highly conserved binding 
site for the tumor suppressor von Hippel Lindau protein (pVHL) is present. The pVHL targets 
a HIF-1α degradation to form a complex that activates the E3 ubiquitin ligase that ubiquiti-
nates HIF-1α. Inactivation of pVHL is associated with von Hippel Lindau cancer syndrome. 
It prevents the binding of pVHL mutations to HIF-1α, leading to structural expression of this 
transcription factor and target genes. Such mutations probably increase angiogenesis potential 
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by continuous VEGF synthesis. The interaction between HIF-1α and pVHL is regulated via 
the hydroxylation of two proline residues of HIF-1α with the prolyl hydroxylase enzyme. In 
the absence of oxygen, this enzyme is no longer active: unmodified prolyl-HIF-1α does not 
interact with pVHL and accumulates [148, 149]. The absolute oxygen requirement of this prolyl 
hydroxylase suggests that this enzyme may function as a direct oxygen sensor. Other pathways 
indicate that HIF-1α stabilization and/or synthesis is also dependent on the PI-3 kinase/Akt 
pathway in the case of hypoxia. The usage of PI-3 K inhibitors prevents accumulation of HIF-1 
[150]. The increase in HIF-1α synthesis is also dependent on the PI-3 K/Akt pathway [151].
HIF-1α stabilization is the first step in HIF-1 activation: For complete transcriptional activ-
ity, sufficient redox conditions, separation from chaperone HSP90, phosphorylation as well 
as coactivators such as CBP/p300 or SRC-1 are required [152, 153]. Hypoxia directly regu-
lates the association of HIF-1α with the coactivator CBP/p300. Similarly to prolyl hydroxy-
lase, it hydroxylates the HIF-1α carboxy-terminal transactivation site on Asn 803 of asparagyl 
hydroxylase, whose activity is tightly bound to the oxygen. This modification prevents the 
association with CBP/p300 in the case of normoxia [154].
HIF-1α is not only essential for a variety of physiological responses in chronic hypoxia but 
also for embryonic survival and cardiac and vascular development. Hif1a−/− mice are not via-
ble: development of Hif1a−/− embryos arrests by day E9.0 and mice die by E10.5 [155, 156]. 
There is a marked regression of blood vessels in the cephalic region and replacement by a 
smaller number of enlarged vascular structures. Loss of pericyte support of the endothelium 
leading to vascular regression is probably responsible for these defects. Massive cell death in 
cephalic mesothelium was observed concurrent with the deterioration of the vessel develop-
ment. Heart development in HIF-1α−/− embryos is also abnormal. In ARNT−/− mice, embryonic 
death probably occurs due to insufficiency of the embryonic component required for vas-
cularization of placenta [157]. Observation of similar vascular abnormalities in HIF-1α and 
VGEF-deficient embryos suggests hypoxia-induced overexpression in VEGF for the develop-
ment of the vascular system.
8.2.8. Pathological responses to hypoxia
Hypoxia due to deteriorated blood flow has detrimental effect on organ structure and func-
tion. This is especially true in prolapse (cerebral ischemia) and heart infarction (myocardial 
ischemia). Hypoxia also plays an important role in the regulation of tumor growth and metas-
tasis. Here, we describe the role of hypoxin in these three pathological conditions.
8.2.9. Cerebral ischemia
High energy requirements compared to low energy reserves make the brain particularly 
susceptible to hypoxic conditions. Although the brain produces a small fraction of total 
body weight (2%), it proportionally accounts for a large percentage of O
2
 consumption. 
The increased O
2
 requirement in physiological conditions is met by a rapid and satisfactory 
increase in cerebral blood flow. However, hypoxemia and ischemia in children suffering 
from severe asphyxia and in prolapse sufferers result in brain damage. Longer periods of 
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hypoxia/ischemia lead to greater effects in the brain. The most sensitive areas appear to be 
the brain stem, hippocampus, and cerebral cortex. If the damage processes and eventually 
oxygenation is not restored, it becomes irreversible. Acute cell death is primarily caused 
by necrosis, but hypoxia also causes by late apoptosis. Although it is the only way to pro-
tect tissue, it should be noted that mainly reactive oxygen species reperfusion induces cell 
death through production and inflammatory cell infiltration. If the decrease in pO
2
 is not too 
severe, it suppresses some of the cell functions; for example, proton synthesis and spontane-
ous electrical activity are suppressed and this condition is called penumbra, which is charac-
terized with return when O
2
 is provided [158, 159].
8.2.10. Myocardial ischemia
Acute coronary syndromes resulting from occlusion of one of the coronaries expose heart to 
ischemic conditions. If reperfusion is achieved after short ischemic periods (<20 minutes), it is 
reversible and not associated with necrosis development, but results in stunning phenomena. 
If the coronary occlusion duration goes beyond this point, a necrosis wave propagates from 
the subendocardium towards the subepicardium. After a few hours, reperfusion does not 
diminish the size of myocardial infarction.
Within seconds of cessation of blood flow energy metabolism shifts from mitochondrial 
respiration to anaerobic glycolysis. Concurrent active contractions are reduced and then 
terminated. Accumulation of lactate and protons in cardiomyocytes induces acidosis and 
osmotic load and subsequent cell edema. In addition, intracellular Ca+2 increases, probably 
due to the combined effect of Na+/Ca+2 modulators activated by cellular acidosis. If this 
happens, it will lead to cell necrosis [160]. To restore aerobic metabolism and to protect 
ischemic myocytes, it is necessary to restore the arterial flow. However, this situation itself 
increases the damage. This process is called ischemia-reperfusion injury. In the first few 
minutes of reperfusion, a large amount of released reactive oxygen radicals is a possible 
cause of this contractile failure.
8.2.11. Tumor angiogenesis
The onset of new vascularization in many primary tumors is defined as the angiogenic 
switch. Several key signaling events have been identified that involve immune/inflamma-
tory responses and genetic mutations, but metabolic stress (hypoxia) is probably the most 
important of these factors [161, 162]. Tumor cells survive in the fluctuations of HIF-1 activa-
tion in oxygen tension. Various studies using HIF-1 mutant cells have shown that HIF-1 has 
profound effects on tumor biology. For example, tumors arising from embryonic stem cells 
with HIF-1α defect show abnormal vascularity and low growth rate [39]. Furthermore, 
HIF-1 is upregulated in a wide range of tumors, and there are important links between 
tumor grade, vascularization, and HIF-1α overexpression [163, 164]. This expression pat-
tern suggests that tumor cells respond to hypoxia caused by HIF-1–mediated angiogenic 
protein expression. The VEGF is the strongest of these and its expression is regulated by 
HIF-1. In addition to promoting VEGF secretion, HIF-1 is also important for hypoxia adap-
tation of tumor cells [165].
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8.2.12. Determination of hypoxemia
Tumor hypoxia is the strongest prognostic factor in various cancers. Hypoxic cells contribute 
to intrinsic radiation resistance. Apoptosis resistance and increased metastasis capacity are 
other contributing factors to this negative outcome. Therefore, the factors that aim to deter-
mine tumor oxygenation have serious clinical safety. A number of studies aim to identify 
a good hypoxia marker that can be used in immunomicroscopy studies [166]. The use of 
2-nitromidazole specifically binding to hypoxic cells has been suggested; pimonidazole and 
EF5 are the best known of these. Reduction enzymes metabolize these drugs in the presence 
of oxygen, but when there is no oxygen they are converted to highly reactive free radical 
molecules that are covalently bound to protein and DNA. Subsequently, drug-protein bind-
ing may be detected by specific antibodies. Studies similar to the work of Evans and his col-
leagues showed the suitability of this method. However, these drugs have the disadvantage 
that they need to be administered from a tissue sample.
The discovery that HIF-1α specifically undergoes hypoxic upregulation and is rapidly 
destroyed in the presence of oxygen suggests that this protein may be an endogenous marker 
of this kind. Several studies examining HIF-1α as an endogenous hypoxia marker have con-
firmed the spatial association of HIF-1α with EF5 and pimonidazole [167]. It should be noted 
that the use of HIF-1α as a hypoxia marker is not easy because the level of HIF-1α is also 
regulated by factors other than hypoxia, such as oncogenic mutations [168].
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